Both in Pharmaceuticals
Acadia Pharmaceuticals vs Dyne Therapeutics
Over the past year ACAD returned −8.0% and DYN returned −25.1%; their daily moves had a correlation of 0.33.
ACAD −8.0% DYN −25.1%Growth of $1, one year, split-adjusted
| Metric | ACAD | DYN |
|---|---|---|
| Price | $20.57 | $18.05 |
| Market cap | $3.54B | $3.37B |
| Today | +0.49% | +4.34% |
| 1 month | +2.3% | +16.9% |
| 6 months | −8.0% | +3.3% |
| Year to date | −23.0% | −7.7% |
| 1 year | −9.4% | −20.1% |
| Revenue growth (YoY) | +16.4% | — |
| Gross margin | 90.8% | — |
| Net margin | 10.2% | — |
| P/E (TTM) | 9.3× | — |
| Price / sales | 3.1× | — |
| Net cash | $956.5M | $685.0M |
| Dividend yield | — | — |
| Volatility (60d) | 43.8% | 59.5% |
| Short % of float | 7.1% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).